GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia - Wikidata - awgldk - TriplyDB

GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia

GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia

http://www.wikidata.org/entity/Q35916950

about

The role of cannabinoid 1 receptor expressing interneurons in behavior.Endogenous cannabinoid signaling at inhibitory interneurons.Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia Cognitive ability is associated with altered medial frontal cortical circuits in the LgDel mouse model of 22q11.2DS Medial frontal GABA is lower in older schizophrenia: a MEGA-PRESS with macromolecule suppression study Wnt signaling: role in Alzheimer disease and schizophrenia.The thalamic reticular nucleus: a functional hub for thalamocortical network dysfunction in schizophrenia and a target for drug discovery.The space where aging acts: focus on the GABAergic synapse Adolescent THC Exposure Causes Enduring Prefrontal Cortical Disruption of GABAergic Inhibition and Dysregulation of Sub-Cortical Dopamine Function Testing the excitation/inhibition imbalance hypothesis in a mouse model of the autism spectrum disorder: in vivo neurospectroscopy and molecular evidence for regional phenotypes.PV Interneurons: Critical Regulators of E/I Balance for Prefrontal Cortex-Dependent Behavior and Psychiatric Disorders.

P2860

Q30417825-64C73ECA-90BA-4A39-ACF1-8317AA378E20 Q33624983-61C7BC84-5CA1-45B9-9B14-3420BD0C07A9 Q33932087-8AC5358A-4E96-44EC-8070-A2464A72A43F Q35423269-C124B3DF-4D76-4A95-9179-3BE6FE8E0B3B Q36113065-6BB45308-932D-4DA3-B932-2689422C58BA Q38060562-540C8DD2-BF5B-42A1-8D30-BDFFFBDAAEE9 Q38317401-2A840843-8019-45D0-9298-0DD3D0F04D7D Q39301908-B21848DC-2F1E-445F-892C-8ABF6DC2C119 Q41201772-2B9C5202-669D-4E6B-98A1-FC66A8BDE4E3 Q41716345-C0FA41C4-FDC3-4A74-B48C-B1EBA60DC35F Q54962793-36B0BCFF-A68D-4E76-8BF3-8649F84DC7C2

P2860

GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia

http://www.wikidata.org/entity/Q35916950

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia

@ast

GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia

@en

type

label

GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia

@ast

GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia

@en

prefLabel

GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia

@ast

GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia

@en

P1433

Q35916950-67FA858A-5AA2-401B-BB5D-EF94D0DBCA4C

P1476

Q35916950-8722D826-CBBD-482A-B817-99F714F2218D

P2093

Q35916950-116D4FD8-B622-4CD6-ABB1-E2BC1E6E9967

P2860

Q35916950-00FCD098-4FB0-4272-B11F-1870BC1E0CFF

Q35916950-06B5C9DE-61A1-40B2-8A6D-0803613DD8FB

Q35916950-08AB8CC8-6ACA-4AD3-8725-5563FC94872F

Q35916950-08DAD435-BE81-4ABE-B118-154BE975D8AE

Q35916950-09ED04AF-19A4-461B-BC08-7A6DB722E944

Q35916950-0E34E83A-9347-46B9-928C-358DD1B49052

Q35916950-121D2CEE-BDB3-4B1D-9496-61B70D466C3E

Q35916950-15212951-6763-491B-93A6-DC08F8069F03

Q35916950-164A2812-51C6-43BA-9D16-095557ED77BF

Q35916950-18A58531-E396-4A5F-BC5A-A4E86AB3F2FE

P304

Q35916950-40E520B1-838B-445F-BD48-9B54EF5FCF2F

P31

Q35916950-4F8A165F-F760-4983-88F3-8F4176E48C3F

P356

Q35916950-B6C594AD-4914-4831-AA95-AB2BA2319A38

P433

Q35916950-4AC6B62B-5395-48CF-8B99-EE07E041EC11

P478

Q35916950-6FBF3E08-28A8-43F6-8136-D06D4AA84B13

P50

Q35916950-DD06C9A2-6638-45DA-BBB0-F146B640C279

P577

Q35916950-EB098CEB-B8FB-4566-9EF0-1D9327EC4148

P5875

Q35916950-A94D54FD-ECDD-409B-84F1-49F9DA496556

P698

Q35916950-37C8EDE3-B70A-4D36-B67D-3D783150FFC8

P921

Q35916950-ECEAFC0D-2356-4C06-A2BB-DA903462F7FB

P932

Q35916950-45A04809-42C1-463D-9C18-86032B2CC330

P356

1570159052773396

P1433

Current Neuropharmacology

P1476

GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia

@en

P2093

David W Volk

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex

GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons

Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons

Cre recombinase: the universal reagent for genome tailoring

Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects

Role of endogenous cannabinoids in synaptic signaling

Multiplicity of mechanisms of serotonin receptor signal transduction

5-HT3 receptors mediate serotonergic fast synaptic excitation of neocortical vasoactive intestinal peptide/cholecystokinin interneurons

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

Cannabis and schizophrenia. A longitudinal study of Swedish conscripts

P304

45-62

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/1570159052773396

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224868637

http://www.w3.org/2001/XMLSchema#string

P698

22545031

http://www.w3.org/2001/XMLSchema#string

P921

P932

3338098

http://www.w3.org/2001/XMLSchema#string